- Home
- CLNN vs MRCC Comparison
CLNN vs MRCC Comparison
Compare CLNN & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | MRCC |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 141.3M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | CLNN | MRCC |
|---|---|---|
| Price | $6.16 | $6.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $32.67 | $8.00 |
| AVG Volume (30 Days) | ★ 314.0K | 97.5K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 11.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $214,000.00 | ★ $43,742,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $87.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.28 | $5.86 |
| 52 Week High | $13.50 | $8.85 |
Technical Indicators
Market Signals| Indicator | CLNN | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 35.65 |
| Support Level | $6.04 | $6.20 |
| Resistance Level | $6.95 | $6.80 |
| Average True Range (ATR) | 0.71 | 0.18 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 31.45 | 5.89 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.